They take a range of forms and are an increasingly common clinical issue with the growing list of cancers for which the immunologic agents are indicated.
In a recent study published in the journal Nature Medicine, researchers conducted serial cardiac assessments in individuals with mild initial coronavirus disease 2019 (COVID-19) who had no history of cardiac disease and significant comorbidities.
Recent research conducted in Thailand on 13- to 18-year-olds revealed one out of 100 children have developed heart inflammation after receiving two doses of the Wuhan coronavirus (COVID-19) [.]
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can begin once a policy recommendation from the CDC is received GAITHERSBURG, Md., Aug. 22, 2022 /PRNewswire/ Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted(NVX-CoV2373) has received expanded emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a two-dose primary series for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in adolescents aged 12 through 17. "Having more vaccine options for use in both adults and adolescents, like the Novavax COVID-19 Vaccine, Adjuvanted will hopefull
A study in Thailand revealed that almost 30 percent of young adults suffered cardiac injuries as a result of the Wuhan coronavirus (COVID-19) vaccines. The paper published Aug. 8 in Preprints [.]